FDA Drug Application (009296) for SERPASIL-APRESOLINE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number009296
Product Number002
FormTABLET;ORAL
Dosage50MG;0.2MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSERPASIL-APRESOLINE
Active IngredientHYDRALAZINE HYDROCHLORIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by NOVARTIS